Paul Hanna

9PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyRespiratory diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 13, 2026
GFR Evaluation Among Patients with Cancer: Insights and Clinical Implications.

Alok Arora, Parnika Shukla, Vinay Srinivasan

|Nov 17, 2025
Nephrotoxicity of conventional chemotherapeutics: part 1-platinum compounds and antimetabolite agents.

Adam Kelly, Sourabh Sharma, Omar Mamlouk

|Oct 17, 2025
Nephrotoxicity of conventional chemotherapeutics: part II-non-platinum agents and miscellaneous nephrotoxic drugs.

Adam Kelly, Sourabh Sharma, Omar Mamlouk

|Apr 25, 2025
Cardiovascular involvement in ANCA-associated vasculitis.

Ahmad Sarmad, Zohreh Gholizadeh Ghozloujeh, Paul E Hanna

|Apr 22, 2024
Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer.

Paul E Hanna, Tianqi Ouyang, Ismail Tahir

|Aug 19, 2023
Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer.

Paul E Hanna, Ian A Strohbehn, Daiana Moreno

Pageof 2